Mid-term pulmonary sequelae after hospitalisation for COVID-19: The French SISCOVID cohort.

ABSTRACT:

Background

Even though COVID-19 clinical features, pathogenesis, complications, and therapeutic options have been largely described in the literature, long-term consequences in patients remain poorly known.

Methods

The French, multicentre, non-interventional SISCOVID study evaluated lung impairment three (M3) and six months (M6) after hospital discharge in patients recovered from COVID-19. Evaluation was based on clinical examination, pulmonary function tests, and chest computed tomography (CT-scan).

Results

Of the 320 included patients (mean age: 61 years; men: 64.1%), 205 had had a severe form of COVID-19, being hospitalised in an intensive care unit (ICU), and requiring high flow nasal cannula, non-invasive ventilation, or invasive mechanical ventilation. At M6, 54

SUBMITTER: Calcaianu G 

PROVIDER: S-EPMC9192129 | biostudies-literature | 2022 Nov

REPOSITORIES: biostudies-literature